Showing 1,401 - 1,420 results of 2,756 for search 'materials dysfunction', query time: 0.13s Refine Results
  1. 1401

    In vivo assessment of endothelial function in small animals using an infrared pulse detector by Cyuan-Cin Liu, Wei-Min Liu, Hsien-Tsai Wu, Chien-Hsing Wang, An-Bang Liu

    Published 2019-01-01
    “…Objective: Endothelial dysfunction is the earliest change in atherosclerosis. …”
    Get full text
    Article
  2. 1402

    Heart valve calcification in patients with coronary heart disease by S. A. Dovgolis, I. Yu. Kucherova, E. A. Kozlov, I. G. Fomina

    Published 2005-02-01
    “…Mitral and aortic valve calcification, regurgitation, ejection fraction, diastolic dysfunction, left cardiac chamber sizes, and atherosclerosis risk factors were studied. …”
    Get full text
    Article
  3. 1403

    Pathogenetic role of the autonomic nervous system in arterial hypotension cardiac remodeling in young women by V. M. Baev, Т. Yu. Agafonova

    Published 2019-03-01
    “…We identified a restrictive type of diastolic dysfunction in women with parasympathicotonia.Conclusion. …”
    Get full text
    Article
  4. 1404

    NEPHROPROTECTIVE EFFECTS OF LISINOPRIL IN THE THERAPY OF HYPERTENSIVE PATIENTS WITH OBESITY by S. G. Shulkina, Е. N. Smirnova

    Published 2018-05-01
    “…To investigate the dynamics of biomarkers of early renal damage in patients with hypertension (HT) and obesity treated with lisinopril and diet therapy.Material and methods. The study included 120 people aged 25 to 55 years (90 patients with HT in combination with obesity and 30 HT patients without obesity). …”
    Get full text
    Article
  5. 1405

    Evaluation of the Psychometric Properties of the Scale A-ONE: An Italian Cross-Sectional Study by Margherita Cerone, Marco Tofani, Giovanni Fabbrini, Giulia Marcellini, Anna Berardi, Claudia Conti, Rita De Santis, Donatella Valente, Giovanni Galeoto

    Published 2021-01-01
    “…This study is aimed at validating the A-ONE scale in an Italian population with Central Nervous System (CNS) dysfunction. Material and Methods. Between May and November 2018, people aged between 60 and 90 with CNS dysfunction were recruited in a hospital in Rome, Italy. …”
    Get full text
    Article
  6. 1406

    Rational Pharmacological Prophylaxis of Gestation Process Complications in Pregnant Women with Varicose Disease by Markin L., Shatylovytch K.

    Published 2014-06-01
    “…Actually, one of the gestating complications of chronic venous insufficiency is the formation of secondary placental dysfunction with clinical implementation in the form of fetal distress, fetal growth retardation syndrome (FGRS), preeclampsia (PE). …”
    Get full text
    Article
  7. 1407

    The technique of three-component regional blockade of the anterior neck region as a component of anesthesia during operations on the thyroid and parathyroid glands by A. A. Alekseev, A. G. Yavorovskiy, E. N. Prazdnikov, A. M. Ovechkin, D. V. Dospekhov, V. S. Vakhromkin, E. A. Sozonova, E. V. Batulina, A. A. Maksimova, E. N. Zolotova

    Published 2024-12-01
    “…The use of various regional blockades as a component of general anesthesia reduces the risk of postoperative complications such as intense pain syndrome, postoperative nausea and vomiting, and postoperative cognitive dysfunction. The study is devoted to the development and description of the technique of regional anesthesia of the anterior surface of the neck during operations on the thyroid and parathyroid glands under ultrasound navigation.The objective was to develop a safe and effective technique of regional anesthesia for operations on the thyroid and parathyroid glands under ultrasound navigation.Materials and methods. …”
    Get full text
    Article
  8. 1408

    Age-Specific Clinical and Laboratory Features and Renal Involvement in Children with MIS-C: A Single Tertiary Centre Experience from Vojvodina by Borko Milanović, Vesna Stojanović, Gordana Vijatov-Ðurić, Marijana Savin, Andrea Ðuretić, Jelena Kesić, Nenad Barišić, Ognjen Ležakov, Ivana Vorgučin, Gordana Vilotijević-Dautović, Katarina Koprivšek

    Published 2025-06-01
    “…The 7–12-year age group showed the highest rate of organ dysfunction. In adolescents (13–18 years), neurological symptoms, the highest BMI values, the greatest prevalence of comorbidities, leukopenia, lymphopenia, and elevated GGT levels were observed. …”
    Get full text
    Article
  9. 1409

    Serum adipokine concentrations in patients with type 2 diabetes: the relationships with distribution, hypertrophy and vascularization of subcutaneous adipose tissue by Vadim V. Klimontov, Dinara M. Bulumbaeva, Nataliya P. Bgatova, Iuliia S. Taskaeva, Nikolay B. Orlov, Olga N. Fazullina, Michael Y. Soluyanov, Sergey V. Savchenko, Vladimir I. Konenkov

    Published 2019-10-01
    “…Academy of Sciences, Novosibirsk, Russia 2Novosibirsk State Medical University, Novosibirsk, Russia BACKGROUND: Adipose tissue (AT) dysfunction plays an important role in metabolic disorders in obesity and type 2 diabetes. …”
    Get full text
    Article
  10. 1410

    A method for the biological age of the heart determination by L. A. Bodretska, I. S. Shapovalenko, A. V. Pisaruk, I. A. Antoniuk-Shchehlova, O. V. Bondarenko, S. S. Naskalova, V. B. Shatylo

    Published 2022-12-01
    “…Significant increase in atrial size with age, development of diastolic dysfunction, increase in left and right ventricular myocardial infarction were found. …”
    Get full text
    Article
  11. 1411

    Early – versus late-onset preeclampsia: differences in risk factors and birth outcomes by Markin L., Medvyedyeva O.

    Published 2017-12-01
    “…EOP starts with a failure to transform the maternal spiral arteries, subsequently followed by alterations of the villous trophoblast, lead to severe placental lesion (early placental dysfunction), hypoxia of the placenta and fetus, the failure of compensatory mechanisms, an increase endothelial dysfunction markers. …”
    Get full text
    Article
  12. 1412

    The impact of chronic heart failure on heart remodeling in patients with atrial fibrillation by V. А. Lysenko, V. V. Syvolap

    Published 2021-07-01
    “…AF patients with signs of CHF had decreased LV EF (55.58 ± 14.65 % vs. 65.44 ± 10.87 %; P = 0.006), systolic velocity of the medial fibrous ring of the mitral valve S (6.92 ± 2.41 cm/s vs. 8.40 ± 2.03 cm/s; P = 0.015), and significantly higher values of TEI RV (0.58 ± 0.16 c. u. vs. 0.48 ± 0.11 c. u.; P = 0.011), but decreased TAPSE values (16.22 ± 4.60 mm vs. 19.54 ± 5.00 mm; P = 0.067), indicating more pronounced systolic dysfunction of both ventricles. Conclusions. Comorbidity of CHF and AF in patients is accompanied by the increased percentage of eccentric hypertrophy (49 %; P = 0.027), more pronounced systolic dysfunction of the left and right ventricles, increased LVEDP, PCWP, systolic pressure in the pulmonary artery, dilation of the inferior vena cava.…”
    Get full text
    Article
  13. 1413

    The Management of Cardiometabolic Risk in MAFLD: Therapeutic Strategies to Modulate Deranged Metabolism and Cholesterol Levels by Annalisa Pezzoli, Ludovico Abenavoli, Marialaura Scarcella, Carlo Rasetti, Gianluca Svegliati Baroni, Jan Tack, Emidio Scarpellini

    Published 2025-02-01
    “…<i>Materials and Methods:</i> For all these reasons, we conducted a narrative review of the literature, and we focused on metabolic dysfunction related to MAFLD, with a special regard for cholesterol metabolism. …”
    Get full text
    Article
  14. 1414

    Pathogenetic and prognostic significance of inflammation and altered ADAMTS-13/vWF axis in patients with severe COVID-19 by V. O. Bitsadze, J. Kh. Khizroeva, J.-Ch. Gris, S. Schulman, A. S. Shkoda, M. V. Tretyakova, N. A. Makatsariya, E. V. Slukhanchuk, L. L. Pankratyeva, M. I. Petrovskiy, I. V. Mashechkin, D. V. Blinov, V. I. Tsibizova, Z. K. Gadaeva, S. S. Panshin, N. V. Samburova, A. D. Makatsariya

    Published 2022-07-01
    “…The activation of innate immune cells including neutrophils results in formation of neutrophil extracellular traps (NETs) and myeloperoxidase (MPO) release that, in turn, contributes to spread of inflammation and microvascular thrombosis.Aim: to evaluate a pathogenetic role and predictive significance for serum markers of inflammation, endothelial dysfunction and hemostatis activation such as vWF, ADAMTS-13 and MPO for in-hospital mortality in severe COVID-19 patients requiring mechanical lung ventilation.Materials and Methods. …”
    Get full text
    Article
  15. 1415

    The use of microvascular endothelial function indicators to calculate functional age of the microcirculation system by O. V. Korkushko, V. B. Shatylo, O. V. Bondarenko, A. V. Pysaruk, I. A. Antonyuk-Shchehlova, S. S. Naskalova, H. V. Duzhak, L. A. Bodretska, I. S. Shapovalenko

    Published 2022-05-01
    “…To find out the possibility of using microvascular endothelial function indicators to determine the biological age (BA) of a person. Materials and methods. 390 patients aged 20–29 years (n = 31), 30–39 (n = 22), 40–49 (n = 45), 50–59 years (n = 72), 60–69 years (n = 129) and 70–79 years (n = 91) were examined. …”
    Get full text
    Article
  16. 1416

    Рrediction risk factors of gastroesophageal reflux disease in children and adolescents with chronic gastroduodenal pathology by L. M. Boiarskа, К. А. Ivanova

    Published 2013-12-01
    “…The main risk factors of its development are acid-peptic factor, Н.pylori, the autonomic nervous system dysfunction, rapid growth, heredity, burdened perinatal history, dysplasia of connective tissue structures (DCTS), environmental factors and lifestyle. …”
    Get full text
    Article
  17. 1417

    Clinical Features and Inhospital Outcomes of Takotsubo (Stress) Cardiomyopathy: Ten Years’ Experience from a Tertiary Care Center in South India by Amit Mandal, John Jose, Oommen K. George, Paul V. George, Viji Samuel Thomson, George Joseph

    Published 2025-04-01
    “…Background: Takotsubo cardiomyopathy is a syndrome which is characterized by transient regional systolic dysfunction, principally, of the left ventricle (LV), mimicking myocardial infarction (MI), but in the absence of angiographic evidence of obstructive coronary artery disease or acute plaque rupture. …”
    Get full text
    Article
  18. 1418

    Clinical efficacy of gliclazide with modified release after myocardial infarction in patients with concomitant type 2 diabetes by N. S. Mykhailovska

    Published 2014-04-01
    “…Objective: to study the effectiveness of gliclazide modified release in patients with Q- myocardial infarction with concomitant type 2diabetes mellitus by its effect on the clinical course of the disease, glucometabolic control and humoral parameters during 12 months of observation. Materials and Methods: we examined 99 patients with Q- myocardial infarction with metabolic syndrome and concomitant type 2diabetes mellitus, 52 men (52.53%) and 47 women (47.47%), average age (62,9 ± 2, 05) years. …”
    Get full text
    Article
  19. 1419

    Optimizing the treatment for gastroesophageal reflux disease in young people: the role and place of rebamipide by I.M. Skrypnyk, I.M. Gorodnytska, G.S. Maslova, B.M. Fylenko

    Published 2025-03-01
    “…Objective: to evaluate the effect of rebami­pide on the restoration of the esophageal protective barrier in the presence of erosive or non-erosive forms of gastroesophageal reflux disease in young patients. Materials and methods. Thirty young patients with GERD aged 18 to 45 years were examined. …”
    Get full text
    Article
  20. 1420